Income Statement
PUMA BIOTECHNOLOGY, INC.
PBYI
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
228.37 | 230.47 | 235.64 | 228.03 | 253.16 | 225.11 | 272.26 | 250.99 | 27.69 | - | - | - | - | - | - |
|
Cost of Revenue
|
58.16 | 64.40 | 62.68 | 55.09 | 63.70 | - | - | 34.62 | - | - | - | - | - | - | - |
|
Gross Profit
|
170.21 | 166.06 | 172.96 | 172.94 | 189.45 | 225.11 | 272.26 | 216.37 | 27.69 | - | - | - | - | - | - |
|
Operating Expenses
|
70.85 | 80.16 | 89.93 | 89.98 | 188.16 | 255.51 | 311.36 | 345.66 | 320.08 | 276.60 | 240.28 | 142.28 | 54.83 | 74.45 | 10.16 |
|
Research & Development
|
62.07 | 54.94 | 50.38 | 52.24 | 71.87 | 97.65 | 132.85 | 164.85 | 207.81 | 222.80 | 208.47 | 122.92 | 45.05 | 49.64 | 0.83 |
|
Selling, General & Administrative
|
70.85 | 80.16 | 89.93 | 89.98 | 116.29 | 118.49 | 141.69 | 146.19 | 106.69 | 53.80 | 31.81 | 19.36 | 9.79 | 24.81 | 9.32 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
99.37 | 85.90 | 83.02 | 82.96 | 1.29 | -30.40 | -39.10 | -129.29 | -292.39 | -276.60 | -240.28 | -142.28 | -54.83 | -74.45 | -10.16 |
|
Non-Operating Income
|
-1.52 | -6.87 | -9.97 | -23.26 | -30.09 | -29.39 | -36.50 | -18.90 | 0.44 | 0.59 | 1.00 | 0.31 | 0.17 | 0.10 | -0.08 |
|
Interest Income
|
4.08 | 4.72 | 2.61 | 0.81 | 0.16 | 0.49 | 2.85 | 1.80 | 1.26 | 0.96 | 0.97 | 0.32 | 0.17 | 0.10 | 0.00 |
|
Interest Expense
|
- | 7.70 | 13.33 | 11.59 | 12.81 | 14.05 | 15.02 | 10.99 | 0.72 | - | - | - | - | - | - |
|
Other Non-Op Income / Expense
|
1.03 | 0.86 | 0.76 | -0.03 | 0.29 | 0.37 | 0.13 | -0.71 | -0.10 | -0.37 | 0.03 | -0.01 | 0.00 | - | -0.08 |
|
Income Before Tax
|
35.78 | 24.10 | 22.67 | 0.46 | -28.80 | -59.79 | - | - | - | - | - | - | - | - | - |
|
Income Tax Expense
|
4.67 | -6.18 | 1.08 | 0.46 | 0.32 | 0.21 | - | - | - | - | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
31.11 | 30.28 | 21.59 | 0.00 | -29.13 | -60.00 | -75.60 | -113.58 | -291.96 | -276.01 | -239.28 | -141.97 | -54.66 | -74.35 | -10.23 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
110.31 | 97.43 | 94.54 | 91.88 | 11.89 | -20.37 | -31.02 | -121.91 | -289.58 | -275.45 | -239.50 | -141.65 | -54.41 | -74.19 | -10.15 |
|
Earnings Per Share (Basic)
|
0.62 | 0.62 | 0.46 | 0.00 | -29,126.00 | 0.40 | - | - | - | - | - | - | - | - | - |
|
Diluted EPS
|
0.61 | 0.62 | 0.45 | 0.00 | - | - | - | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
50.01 | 48.65 | 47.13 | 44.67 | - | - | - | - | - | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
50.65 | 49.10 | 47.55 | 44.93 | - | - | - | - | - | - | - | - | - | - | - |
|
Comprehensive Income
|
31.14 | 30.29 | 21.59 | 0.00 | -29.13 | -60.06 | -75.52 | -113.59 | -291.94 | -275.88 | -239.34 | -142.06 | -54.66 | - | - |